Pages that link to "Q38642648"

The following pages link to Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update (Q38642648):

Displaying 17 items.

• Management of elderly and unfit patients with chronic lymphocytic leukemia (Q30243914) (← links)
• Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells (Q37725415) (← links)
• Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose? (Q38700745) (← links)
• Long-term safety experience with bendamustine for injection in a real-world setting (Q38844017) (← links)
• Recent advances in therapy of chronic lymphocytic leukaemia (Q38862525) (← links)
• Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials (Q38979354) (← links)
• Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. (Q39005626) (← links)
• A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan. (Q40345871) (← links)
• Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment (Q42364241) (← links)
• Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event (Q50081496) (← links)
• Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14). (Q50187344) (← links)
• Bendamustine plus rituximab in chronic lymphocytic leukemia: is there life in the old dog yet? (Q55362022) (← links)
• Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma (Q89581523) (← links)
• Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study (Q89830053) (← links)
• Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen (Q91341162) (← links)
• Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole (Q93162433) (← links)
• Molecular Hybrids Integrated with Benzimidazole and Pyrazole Structural Motifs: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies (Q94548254) (← links)